Longeveron (LGVN) Capital Expenditures (2020 - 2026)
Longeveron (LGVN) posted Capital Expenditures of $103,000 for Q2 2026, down 36.0% from $161,000 a year earlier.
Powered by 
Analysis
Longeveron (LGVN) Capital Expenditures (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Longeveron was $160,000, down 74.6% year-over-year; for FY2025, it was $245,000, down 62.6% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 13.3% (FY2020 to FY2025).
- In prior years, Longeveron's Capital Expenditures was $655,000 in FY2024 (+117.6%), $301,000 in FY2023 (-47.1%), $569,000 in FY2022 (+72.4%) and $330,000 in FY2021 (+151.9%).
- Quarterly Capital Expenditures has run from a low of $3,000 in Q3 2023 to a high of $430,000 in Q3 2024 over five years.
- On a year-over-year basis, Capital Expenditures increased in 1 of the last five quarters, with an average decline of 32.8%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q4 2023, with growth of 148.5%; the weakest was Q3 2023, with a decline of 99.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Longeveron | 8.14 Mn | -31.66 Mn | 182,000.00 | 103,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 103,000.00 |
| Sep 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 161,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 430,000.00 |
| Jun 30, 2024 | 196,000.00 |
| Mar 31, 2024 | 16,000.00 |
| Dec 31, 2023 | 164,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 92,000.00 |
| Mar 31, 2023 | 42,000.00 |
| Dec 31, 2022 | 66,000.00 |
| Sep 30, 2022 | 378,000.00 |
| Jun 30, 2022 | 78,000.00 |
| Mar 31, 2022 | 47,000.00 |
| Dec 31, 2021 | 312,000.00 |
| Dec 31, 2020 | -13,000.00 |
| Sep 30, 2020 | 13,000.00 |
| Jun 30, 2020 | 1,000.00 |
API Access
Longeveron Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=LGVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "LGVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=LGVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();